title: Tumour cells produce receptor activator of NF-kappaB ligand (RANKL) in skeletal metastases.
authors.forename: L
authors.initials: L
authors.lastname: Huang
authors.forename: Y Y
authors.initials: YY
authors.lastname: Cheng
authors.forename: L T C
authors.initials: LT
authors.lastname: Chow
authors.forename: M H
authors.initials: MH
authors.lastname: Zheng
authors.forename: S M
authors.initials: SM
authors.lastname: Kumta
mesh_terms: D000230:Adenocarcinoma / Q000556:secondary*; D001859:Bone Neoplasms / Q000556:secondary*; D002352:Carrier Proteins / Q000378:metabolism*; D005260:Female; D006801:Humans; D008024:Ligands; D008297:Male; D008562:Membrane Glycoproteins / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism; D009363:Neoplasm Proteins / Q000378:metabolism*; D010014:Osteolysis / Q000378:metabolism; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B
chemical_list: D002352:Carrier Proteins; D008024:Ligands; D008562:Membrane Glycoproteins; D016328:NF-kappa B; D009363:Neoplasm Proteins; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human